Urine: A Promising Source for Breast Cancer Biomarker Discovery

Breast cancer (BC) is a complex disease, and biomarker development plays a crucial role in its diagnosis and treatment. Urine presents a highly promising source for BC biomarker discovery due to several key advantages.

Many biomarkers specific to BC can be found in urine samples. This is because soluble markers, which indicate the presence or progression of BC, are directly secreted into the urine. This makes urine a valuable source for detecting these soluble markers.

Urine is a relatively stable liquid component, providing an environment where biomarkers remain stable, allowing for accurate detection and analysis. This stability ensures reliable test results and reduces the chances of false readings.

Furthermore, urine sampling is a non-invasive method for collecting specimens. This eliminates the need for uncomfortable or painful procedures, leading to high patient compliance. This high compliance allows for a larger pool of samples for research and analysis.

Overall, the abundance of biomarkers in urine, its stability as a liquid component, and the non-invasive nature of urine sampling make it a valuable resource for BC biomarker research.